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A b s t r A c t
Tobacco use is the single most important preventable health risk in the developed 
world. Smoking-related mortality is on the rise. Most smoking-associated deaths re-
late to lung cancer, chronic obstructive pulmonary disease and coronary heart dis-
ease. Epidemiological studies suggest that passive smoking is nearly as harmful as 
active. In the adult population passive smoking can cause coronary heart disease and 
lung cancer. Smoking ban in public places has been implemented in most countries 
of the Western World with a high degree of compliance. The results of several tri-
als assessing the effectiveness of this measure in public health are encouraging, as a 
consistent decrease in the incidence of acute myocardial infarction has been reported 
for the period after the legislation. A brief overview of these data is herein provided. 
I N t r O D U c t I O N
Tobacco use is the single most important preventable health risk in the developed 
world. Smoking is causatively related to a wide range of diseases, including many types 
of cancer, chronic obstructive pulmonary disease, cardiovascular, cerebrovascular and 
peripheral vascular disease, and peptic ulcer.1 It is the second leading risk factor for 
mortality worldwide, accounting for almost 5 million deaths annually (3.84 million in 
men and 1 million in women), including 848 000 due to cardiovascular disease.2 It is 
estimated that smoking-related mortality will rise worldwide from 3 million annually 
(1995) to 10 million annually by 2030. 
Data from the World Health organization (WHO) confirm that smoking among 
males older than 15 years old in the Western Pacific Region exceeds 50%, while women 
smokers prevail in the European Region with their percentage reaching 22%. The rates 
at which adolescent boys use tobacco average around 18% globally.
Second-hand smoke is the smoke that is inhaled in restaurants, offices, homes or 
other closed spaces when people use tobacco products. There are more than 4000 
chemicals in tobacco smoke, of which >250 are known to be harmful and over 50 are 
known to cause cancer. There is no safe level of exposure to second-hand tobacco 
smoke. In adults, passive smoking can cause lung cancer and coronary heart disease. 
In infants, it causes sudden death. In pregnant women, it causes low birth weight. 
Passive smoking causes >600 000 premature deaths per year. Epidemiological studies 
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suggest that passive smoking is nearly as harmful as active, in 
terms of cardiovascular health parameters and outcome such 
as platelet and endothelial function, arterial stiffness, athero-
sclerosis, oxidative stress, inflammation, heart rate variability, 
energy metabolism, acute coronary syndrome provocation and 
infarct size.3,4 Every individual on the planet should be able 
to breathe tobacco-smoke-free air. Smoke-free laws protect 
the health of non-smokers, are or should be popular, do not 
harm business and encourage smokers to quit. All people 
should be protected by comprehensive national smoke-free 
laws that should be implemented and all individuals, groups, 
businesses and societies need to abide by (http://www.who.
int/mediacentre/factsheets/fs339/en/). 
c l I N I c A l  s t U D I E s
Over the last decade significant effort has been made in 
the western world to change the smoking habits of the popu-
lation. After the relatively poor results of the anti-smoking 
campaigns, several states have prohibited smoking in public 
places. The established deleterious effects of passive smoking 
have provided a strong moral rationale for this measure which 
aspires to reduce the morbidity and mortality associated with 
tobacco use. Several studies have been conducted in recent 
years to assess the efficacy of the enforcement of smoking 
banning laws. In a small region in Montana, USA, smoking 
was prohibited in workplaces and public places for 6 months 
in the year 2002. The evaluation of the hospital archives for 
these months during the years 1998-2003 revealed that during 
the law enforcement period there was a significant decrease in 
admissions for acute myocardial infarction (AMI) compared 
to previous and subsequent years. Moreover, in a nearby ter-
ritory not subject to such a law, no difference in the number 
of admissions for AMI was noted.5 
In 2005 smoking was banned in indoor public places in 
Italy. The discharge records of hospitals in the Piedmont re-
gion were examined and the incidence of AMI was compared 
between a time period during the smoking ban and the same 
months in the years before it. The rates of admission for AMI 
were significantly lower during the ban (922 vs 832 cases, sex- 
and age-adjusted rate ratio, 0.89; 95% confidence interval, 
0.81–0.98) for people younger than 60 years old. When the 
whole study population regardless of age was evaluated, no 
difference was noted. This was also the case for individuals 
older than 60 years old. 6
The same team conducted a larger, country-wide study 
evaluating the occurrence rate of acute coronary syndromes 
(ACS) in a period of 5 years, from 2002 to 2006 which included 
three years preceding and two years following the smoking ban. 
The population was analyzed with regard to the age (above 
or below 70 years old) and several variables were included 
in secondary analysis, such as geographical distribution and 
fluctuations in all-cause hospital admissions. On a total number 
of events exceeding 900000, the rate ratio (RR) for all ages 
for the ban compared with the pre-ban period was 0.98 (95% 
confidence interval-CI 0.97–1.00). However, among people 
under 70 years of age, the RR of ACS for same comparison 
was 0.96 (95% CI: 0.95–0.98), representing a 4% decrease, 
regardless of the gender.7
Cesaroni et al examined the hospital archives in Rome 
and the regional register of causes of deaths to evaluate the 
incidence of ACS in individuals 35-84 years of age from 2000 
to 2004 and compare it with 2005 data which represent the 
post-legislation period. In order to compensate for various 
confounding factors, information regarding indoor air pollu-
tion, influenza epidemics, weather conditions, cigarette sales 
and smoking habits of the population was taken into account. 
A statistically significant reduction occurred in acute coronary 
events after the smoking ban in 35- to 64-year-olds (RR 0.89, 
95% CI 0.85 to 0.93) and in 65- to 74-year-olds (RR 0.92, 
95% CI 0.88 to 0.97) reaching 12% and 8% respectively. In 
both age groups, out-of-hospital deaths and hospitalizations 
also decreased. In the oldest group (75- to 84-year-olds) no 
difference was detected. The cardiovascular event reduction 
was more apparent among men in the youngest population and 
young people living in low socioeconomic areas. According 
to particulate matter measurements and cigarette sales, the 
indoor air quality improved and smoking decreased. Thus, 
both passive and active smoking exposure rates dropped. As-
sessing the differential effect of these exposure conditions in 
cardiovascular events, the authors suggest that the benefits 
reported can be mainly attributed to the reduction of the 
exposure to passive smoking.8
A more extended study using data from four Italian regions 
showed that admissions for AMI decreased significantly within 
one year of the non-smoking law enforcement. However, the 
age and gender analysis revealed that this effect is apparent 
only in men and in the age classes 45-49 and 50-54 years of age.9
In Ireland, smoking ban in all enclosed public areas was 
introduced in 2004. Cronin et al examined data from a prospec-
tive register of all adult patients admitted due to an ACS in the 
hospitals of South-West Ireland from 2003 until 2007. By the 
first year of the implementation of the ban, the rate of admis-
sions for ACS reduced by 12% in comparison to the previous 
year (177.9/100,000 from 205.9/100 000, 95% confidence interval 
[CI]: 164.0-185.1; P = 0.002). This result was confined to men 
and current smokers. A further reduction by 13% was noted 
during the third year of the smoking prohibition.10
However, smoking influence is not confined to cardio-
vascular system. A study assessing the total (non-trauma) 
and cause-specific mortality in patients over 35 years old was 
conducted in Ireland from 2000 until 2007, incorporating 3.75 
years of post-ban follow-up. Adjustments for influenza activity, 
smoking prevalence and seasonality were made. The results 
were impressive with a 13% decrease in all-cause mortality 
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(RR: 0.87; 95% CI: 0.76–0.99), a 26% reduction in ischemic 
heart disease (RR: 0.74; 95% CI: 0.63–0.88), a 32% reduction 
in stroke (RR: 0.68; 95% CI: 0.54–0.85), and a 38% reduc-
tion in chronic obstructive pulmonary disease (COPD) (RR: 
0.62; 95% CI: 0.46–0.83) mortality. Interestingly, decreases 
in mortality from ischemic heart disease, stroke, and COPD 
were recorded in individuals over 65 years old.11
In the Canton of Graubuenden, Switzerland, data on AMI 
(both STEMI and NSTEMI) admissions were collected from 
the tertiary hospital which holds the only cardiac catheterization 
laboratory, through the period of March 2008 to February 2009 
(smoking ban active from March 2008) and were subsequently 
compared with those of the previous two years. In the two years 
preceding the prohibitory legislation, the number of patients 
suffering AMI was similar (229 vs. 242; p = not significant). 
In the following year the number dropped significantly to 183 
(22% reduction, p<0.05 vs each of the previous two years). 
This result was mainly driven by a significant reduction in AMI 
rates in men (24%, p<0.05), while in women a non significant 
reduction of 17% was observed. Non smokers and patients 
with prior myocardial infarction or percutaneous coronary 
intervention enjoy more benefit.12
In the subsequent year the results remained the same, 
indicating that public health improvement was consistent over 
time. The late results were also compared with data from a 
nearby region where no smoke-free laws were active, as an 
estimate of the temporal distribution of AMI throughout the 
country. In this area the incidence of AMI did not show any 
change during the 3-year period of evaluation. Furthermore, 
markers of air pollution were measured and there was no 
relationship to the occurrence of AMI.13 
In the UK, smoke free legislation was enforced in July 
2007. Hospital admissions for coronary events of patients older 
than 16 years of age, from 2004 to 2012, were analyzed by age, 
sex and socio-economic status. Between the first and last two 
years of the study (2005-2006 and 2010-2011), AMI admissions 
decreased overall by 41.6% in men (from 325.3/100000 to 
190/100000) and by 42.6% (from 148.7/100000 to 85.3/100000) 
in women (rate ratios 0.584 and 0.574 respectively), without any 
significant differences with regard to the socio-economic level.14
In Spain, Aguero et al compared the occurrence rate of 
AMI between a four-year period before the smoking ban law 
implementation (2003-2005) and a three-year period follow-
ing this legislation (2006-2008). Data were derived from the 
discharge reports of the reference hospital of the region and 
from all death certificates containing causes of death compatible 
with AMI, in order to include out-of-hospital coronary events. 
A decrease in population AMI incidence in the post-ban period 
(relative risk [RR]: 0.89; 95% CI: 0.81–0.97) was observed 
especially among women (RR: 0.82), people aged 65–74 years 
(RR: 0.82) and passive smokers (RR: 0.85). Similar results 
were obtained when evaluating for hospitalized patients only. 
AMI-related mortality was also reduced in the years following 
smoking prohibition (RR:0.82; 95% CI: 0.71–0.94). 15
A study coming from Germany analyzing the hospital 
records from 2006 to 2010 confirmed the previous findings of 
decrease in admissions due to STEMI after the implementa-
tion of the smoking-free laws, from 65 /month in 2006-2007 to 
55/month in 2008-2010, which corresponds to 16% reduction 
(p < 0.01). This result was particularly obvious among non 
smokers, while smokers did not seem to benefit from this 
preventive measure.16
In the Netherlands, de korte-de Boer et al evaluated the 
incidence of out-of-hospital sudden cardiac death based on the 
ambulance registry in the region of South Limburg. A small 
but statistically significant reduction of 6.8% (p=0.043) was 
observed post-ban compared with the pre-ban period.17
In the city of Bowling Green, Ohio, smoking was declared 
illegal in public places in March 2002. The rate of hospital 
admissions for smoking-related diseases was evaluated for 
a period from 1999 to2005 and compared to corresponding 
data from another city in the same state where no such law 
was in power. The results were positive with the largest reduc-
tion observed for coronary heart disease, where rates were 
decreased significantly by 39% after 1 year and by 47% after 
3 years following the implementation of the ordinance in the 
study city (p=0.036). In the control one, no significant change 
was noted (p=0.183).18
In France, over 867,000 hospitalizations for ACS were re-
corded between 2003 and 2009. The admission rate variation, 
adjusted for age and gender was investigated before and after 
the smoking-free laws. In contrast with the aforementioned 
studies, all reductions reported were statistically insignificant. 
The authors in order to explain the result comment that coro-
nary events were decreasing in the country well before the 
smoking ban legislation and that the rates of active smoking 
increased during the study period. 19
A national smoking ban was implemented in Denmark in 
2007. According to a study, spanning a 7-year period (5 years 
before and 2 years after implementation of the smoking ban), 
a significant reduction in the number of AMI-admissions was 
found in the last 3 years of the study period. The significant 
reductions were found one year before the ban (relative rate 
-RR = 0.86, 95% confidence interval -CI 0.79-0.94), one year 
after the ban (RR = 0.77, 95% CI 0.71-0.85) and two years after 
the ban (RR = 0.77, 95% CI 0.70-0.84).20 The authors concluded 
that their results could be explained by the incremental enact-
ment of smoking bans in Denmark and the implementation of 
a nation-wide ban on industrially produced trans-fatty acids 
in food in 2004.20 
c O N c l U s I O N
In conclusion, smoking ban has been implemented in 
most countries of the Western World with a high degree of 
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compliance. Several trials have been conducted to assess the 
effectiveness of this measure in public health. The results 
are encouraging, as a consistent decrease in the incidence of 
cardiovascular episodes has been reported for the period after 
the legislation. The benefit seems more important in younger 
patients, in males and in passive smokers, a result that can be 
expected since the aim of these laws was to reduce secondhand 
smoke exposure and prevent smoking-related morbidity in 
non smokers.
r E F E r E N c E s
 1. Fagerström K. The epidemiology of smoking: health conse-
quences and benefits of cessation Drugs 2002; 62 Suppl 2:1–9.
 2. Ezzati M, Lopez AD. Estimates of global mortality attributable 
to smoking in 2000. Lancet 2003; 362:847–852.
 3. Barnoya J, Glantz SA. Cardiovascular effects of second-
hand smoke: nearly as large as smoking. Circulation 2005; 
111:2684–2698.
 4. Raupach T, Schafer K, Konstantinides S, et al. Secondhand 
smoke as an acute threat for the cardiovascular system: a 
change in paradigm. Eur Heart J 2006; 27:386–392.
 5. Sargent RP, Shepard RM, Glantz SA. Reduced incidence of 
admissions for myocardial infarction associated with public 
smoking ban: before and after study BMJ 2004; 328:977–983. 
 6. Barone-Adesi F, Vizzini L, Merletti F, Richiardi L. Short-
term effects of Italian smoking regulation on rates of hospital 
admission for acute myocardial infarction Eur Heart J 2006; 
27: 2468–2472.
 7. Barone-Adesi F, Gasparrini A, Vizzini L, Merletti F, Richiardi 
L. Effects of Italian smoking regulation on rates of hospital 
admission for acute coronary events: A country-wide study. 
PLoS ONE 2011; 6: e17419. 
 8. Cesaroni G, Forastiere F, Agabiti N, Valente P, Zuccaro P, Pe-
rucci CA. Effect of the Italian smoking ban on population rates 
of acute coronary events Circulation 2008; 117:1183–1188.
 9. Vasselli S, Papini P, Gaelone D, et al. Reduction incidence of 
myocardial infarction associated with a national legislative 
ban on smoking. Minerva Cardioangiol 2008; 56:197–203.
 10. Cronin EM, Kearney PM, Kearney PP, Sullivan P, Perry IJ on 
behalf of the Coronary Heart Attack Ireland Registry (CHAIR) 
Working Group. Impact of a National Smoking Ban on Hospital 
Admission for Acute Coronary Syndromes: A Longitudinal 
Study. Clin Cardiol 2012; 35:205–209.
 11. Stallings-Smith S, Zeka A, Goodman P, Kabir Z, Clancy L. 
Reductions in cardiovascular, cerebrovascular, and respiratory 
mortality following the National Irish Smoking Ban: inter-
rupted time-series analysis. PLoS ONE 2013; 8:e62063.
 12. Trachsel LD, Kuhn MU, Reinhart WH, Schulzki T, Bonetti 
PO. Reduced incidence of acute myocardial infarction in the 
first year after implementation of a public smoking ban in 
Graubuenden, Switzerland. Swiss Med Wkly 2010; 140:133–
138.
 13. Bonetti PO, Trachsel LD, Kuhn MU, et al. Incidence of acute 
myocardial infarction after implementation of a public smoking 
ban in Graubünden, Switzerland: Two year follow-up. Swiss 
Med Wkly 2011; 141:w13206.
 14. Liu A, Guzman Castillo M, Capewell S, Lucy J, O’ Flaherty 
M. Reduction in myocardial infarction admissions in Liverpool 
after the smoking ban: potential socioeconomic implications 
for policymaking. BMJ Open 2013; 3:e003307.
 15. Aguero F, Degano IR, Subirana I, et al. Impact of a partial 
smoke-free legislation on myocardial infarction incidence, 
mortality and case-fatality in a population-based registry: The 
REGICOR Study. PLoS ONE 2013; 8:e53722.
 16. Schmucker J, Wienbergen H, Seide S, et al. Smoking ban in 
public areas is associated with a reduced incidence of hospital 
admissions due to ST-elevation myocardial infarctions in non-
smokers. Results from the BREMEN STEMI REGISTRY. Eur 
J Prev Cardiol 2013; Apr 30. [Epub ahead of print]
 17. de Korte-de Boer D, Kotz D, Viechtbauer W, et al. Effect of 
smoke-free legislation on the incidence of sudden circulatory 
arrest in the Netherlands. Heart 2012; 98:995–999.
 18. Khuder SA, Milz S, Jordan T, Price J, Silvestri K, Butler P. The 
impact of a smoking ban on hospital admissions for coronary 
heart disease. Prev Med 2007; 45:3–8.
 19. Séguret F, Ferreira C, Cambou JP, Carrière I, Thomas D. 
Changes in hospitalization rates for acute coronary syndrome 
after a two-phase comprehensive smoking ban. Eur J Prev 
Cardiol 2013 Aug 5. [Epub ahead of print] 
 20. Christensen TM, Moller L, Jorgensen T, Pisinger C. The 
impact of the Danish smoking ban on hospital admissions for 
acute myocardial infarction. Eur J Prev Cardiol 2014;21:65–73.
